| Primary |
| Anaesthesia |
30.0% |
| Oral Surgery |
8.5% |
| Drug Use For Unknown Indication |
7.7% |
| General Anaesthesia |
7.7% |
| Induction Of Anaesthesia |
7.7% |
| Asthma |
6.9% |
| Anaesthetic Premedication |
6.2% |
| Product Used For Unknown Indication |
5.4% |
| General Anesthesia |
3.8% |
| Maintenance Of Anaesthesia |
3.1% |
| Preoperative Care |
2.3% |
| Detoxification |
1.5% |
| Gastrectomy |
1.5% |
| Hip Arthroplasty |
1.5% |
| Sedation |
1.5% |
| Status Epilepticus |
1.5% |
| Accidental Exposure |
0.8% |
| Caesarean Section |
0.8% |
| Craniotomy |
0.8% |
| Induction And Maintenance Of Anaesthesia |
0.8% |
|
| Haemodynamic Instability |
6.9% |
| Hyperthermia Malignant |
6.9% |
| Kounis Syndrome |
6.9% |
| Muscle Rigidity |
6.9% |
| Nausea |
6.9% |
| Nuclear Magnetic Resonance Imaging Brain Abnormal |
6.9% |
| Overdose |
6.9% |
| Respiratory Distress |
6.9% |
| Rhabdomyolysis |
6.9% |
| Amniotic Fluid Volume Decreased |
3.4% |
| Arteriospasm Coronary |
3.4% |
| Bronchospasm |
3.4% |
| Cardio-respiratory Arrest |
3.4% |
| Condition Aggravated |
3.4% |
| Death |
3.4% |
| End-tidal Co2 Increased |
3.4% |
| Epilepsy |
3.4% |
| Heart Sounds Abnormal |
3.4% |
| Hepatic Failure |
3.4% |
| Hepatorenal Syndrome |
3.4% |
|
| Secondary |
| Anaesthesia |
24.2% |
| Drug Use For Unknown Indication |
16.3% |
| General Anaesthesia |
16.0% |
| Induction Of Anaesthesia |
8.3% |
| Product Used For Unknown Indication |
7.7% |
| Maintenance Of Anaesthesia |
4.9% |
| Premedication |
3.7% |
| Drug Exposure During Pregnancy |
3.4% |
| Prophylaxis |
2.7% |
| Musculoskeletal Pain |
1.8% |
| Status Epilepticus |
1.5% |
| Hypotension |
1.5% |
| Anaesthesia Reversal |
1.3% |
| Epidural Anaesthesia |
1.3% |
| Neuralgia |
1.1% |
| Neuromuscular Blockade |
1.1% |
| Neuromuscular Blockade Reversal |
0.9% |
| Hypertension |
0.8% |
| Sedation |
0.8% |
| Drug Detoxification |
0.7% |
|
| Therapeutic Agent Toxicity |
10.4% |
| Torsade De Pointes |
10.4% |
| Ventricular Tachycardia |
7.5% |
| Tachypnoea |
6.7% |
| Myotonia |
6.0% |
| Somatoform Disorder |
6.0% |
| Sinus Tachycardia |
5.2% |
| Tearfulness |
4.5% |
| Unresponsive To Stimuli |
4.5% |
| Urinoma |
4.5% |
| Vomiting |
4.5% |
| Conversion Disorder |
3.7% |
| Respiratory Distress |
3.7% |
| Shock |
3.7% |
| Tachycardia |
3.7% |
| Death |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Hypotension |
3.0% |
| Incorrect Route Of Drug Administration |
3.0% |
| Procedural Vomiting |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.0% |
| Anaesthesia |
12.4% |
| Induction Of Anaesthesia |
9.5% |
| Maintenance Of Anaesthesia |
8.0% |
| General Anaesthesia |
6.5% |
| Coronary Artery Bypass |
5.5% |
| Drug Use For Unknown Indication |
5.3% |
| Premedication |
2.8% |
| Sedation |
2.3% |
| Hypertension |
2.3% |
| Catheterisation Cardiac |
2.2% |
| Aortic Valve Replacement |
1.8% |
| Hypotension |
1.6% |
| Major Depression |
1.6% |
| Neuralgia |
1.5% |
| Pain |
1.5% |
| Analgesic Therapy |
1.4% |
| Myelitis Transverse |
1.4% |
| Mitral Valve Replacement |
1.3% |
| Nasopharyngitis |
1.3% |
|
| Pain |
12.4% |
| Vomiting |
7.1% |
| Anhedonia |
6.5% |
| Emotional Distress |
6.5% |
| Renal Failure Acute |
6.5% |
| Renal Failure |
5.9% |
| Serotonin Syndrome |
5.9% |
| Therapeutic Agent Toxicity |
5.3% |
| Drug Withdrawal Syndrome |
4.7% |
| Injury |
4.7% |
| Fear |
4.1% |
| Unevaluable Event |
4.1% |
| Anxiety |
3.5% |
| Neuromuscular Blockade |
3.5% |
| Renal Impairment |
3.5% |
| Shock Haemorrhagic |
3.5% |
| Ventricular Fibrillation |
3.5% |
| Multi-organ Failure |
2.9% |
| Myoclonus |
2.9% |
| Procedural Complication |
2.9% |
|
| Interacting |
| General Anaesthesia |
37.0% |
| Osteotomy |
16.0% |
| Musculoskeletal Pain |
8.8% |
| Neuralgia |
6.8% |
| Pain |
5.7% |
| Anaesthesia |
5.0% |
| Varicose Vein Operation |
5.0% |
| Drug Use For Unknown Indication |
4.6% |
| Maintenance Of Anaesthesia |
3.9% |
| Induction Of Anaesthesia |
3.1% |
| Product Used For Unknown Indication |
1.7% |
| Analgesia |
1.1% |
| Type 2 Diabetes Mellitus |
0.6% |
| Endotracheal Intubation |
0.4% |
| Antiemetic Supportive Care |
0.2% |
| Dementia Alzheimer's Type |
0.2% |
|
| Sinus Tachycardia |
60.0% |
| Myotonia |
20.0% |
| Drug Interaction |
8.0% |
| No Adverse Event |
6.0% |
| Movement Disorder |
2.0% |
| Myoclonus |
2.0% |
| Torsade De Pointes |
2.0% |
|
